Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

Ozempic is now available in pill form for people with type 2 diabetes. Novo Nordisk says the oral GLP-1's new lower-dose ...

Novo Nordisk announced that starting Monday, May 4, Ozempic® (semaglutide) tablets 1.5 mg, 4 mg, and 9 mg will be available ...

Novo Nordisk (NVO) stock is in focus as the company launches oral semaglutide as Ozempic pill for patients with type 2 ...

The newly approved oral formulation features a smaller pill size in 1.5mg, 4mg, and 9mg strengths while maintaining the efficacy and safety profile of the previous oral semaglutide version.

Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s rolling out an “Ozempic ...

Novo said the relaunched Ozempic pills are as safe and effective as Rybelsus tablets, which contain the same main ingredient, semaglutide, though in a different formulation and dose structure.

Health Canada has approved the second generic version of brand-name Ozempic, this one manufactured by Canada's largest ...

Drugs developed for the treatment of type 2 diabetes or obesity-related conditions have stood out due to their weight-loss ...

Genetic response gap: A Stanford-led study found a PAM gene variant that makes some people less responsive to GLP-1 drugs, explaining why 1 in 10 users see no benefit. Underreported side effects: AI ...

This continuing education course details the role of GLP-1 injectables in managing chronic conditions and overweight/obesity, ...

Novo Nordisk A/S is rebranding an existing, less-popular diabetes tablet as Ozempic in the US in a bid to capitalize on the ...